adjuvant immunotherapy using HSP70mRNA encoding dendritic cells after hepatectomy for the patients with hepatocellular carcinoma
| Project/Area Number |
23591988
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Digestive surgery
|
|---|
| Research Institution | Yamaguchi University |
|---|
Principal Investigator |
TAMESA TAKAO 山口大学, 医学部附属病院, 講師 (30359905)
|
|---|
| Project Period (FY) |
2011 – 2013
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2013: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2011: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
|---|
| Keywords | 肝細胞癌 / 術後補助療法 / 樹状細胞療法 |
|---|
| Research Abstract |
A Phase 1/2 study of adjuvant immunotherapy using HSP70mRNA encoding dendritic cells after hepatectomy for the patients with hepatocellular carcinoma was performed. Patients were randomly assigned to DC group or surgery group. The safety and the efficacy were evaluated. First 9 patients were recruited to confirm the safety as phase 1 study. (1)Phase 1/2 study: The safety of this therapy was confirmed. All patients (DC group: 18 cases, surgery group: 8 cases) were alive, currently in progress. (2)Immunological assessment :(1)ossibility of non-specific immunoreaction in NK cells and B cells was suggested. (2)Possibility of was specific immunoreaction for HSP70 was suggested by ELISpot assay.
|
Report
(4 results)
Research Products
(3 results)
